Imprimis Pharmaceuticals changes name to Harrow Health
Essential IR Insights Newsletter Fall - 2023
A Corporation Clearly Pinpoints Activist Investor Activity
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Imprimis Pharmaceuticals Inc. said it changed its name to Harrow Health Inc. and will trade as HROW on the Nasdaq Capital Markets beginning Jan. 2, 2019.
Harrow Health owns a portfolio of healthcare businesses, including an ophthalmology pharmaceutical compounding business called ImprimisRx.
